verve therapeutics - Search News

News

Eli Lilly Buys Verve Therapeutics

Eli Lilly to Acquire Verve Therapeutics for Up to $1.3 Billion

Eli Lilly agreed to acquire Verve Therapeutics for about $1 billion upfront, adding a potential treatment for cardiovascular disease to its portfolio.Under the agreement, the pharmaceutical company will buy all of the gene-editing startup’s shares outstanding for $10.

· 17h · on MSN

Eli Lilly’s $1.3 Billion Bid Sends Verve Therapeutics Stock Soaring. What to Know.

· 11h · on MSN

Eli Lilly Co. to buy gene-editing startup Verve to develop cardiac drugs

20h

Eli Lilly to acquire gene-editing therapy developer Verve Therapeutics for up to $1.3 billion, companies say

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

9hon MSN

These Stocks Are Moving the Most Today: Sunrun, Enphase, Verve Therapeutics, Palantir, Tesla, T-Mobile, Jabil, and More

Stocks declined Tuesday and oil prices rose as Israel and Iran continued to exchange missile attacks and hopes for a quick ...

15hon MSN

This one-and-done heart-disease treatment just got a $1.3 billion endorsement from Eli Lilly

Verve Therapeutics’ stock was rallying by a record 80% on Eli Lilly’s premium purchase price for the drug-development company ...

Benzinga.com15h

5 Analysts Assess Verve Therapeutics: What You Need To Know

Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Verve Therapeutics VERV in the last three months. The table below provides a snapshot of their ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results